Thu, March 1, 2018
Wed, February 28, 2018
Tue, February 27, 2018

Andrew Schenker Maintained (THC) at Sell with Increased Target to $16 on, Feb 28th, 2018

Andrew Schenker of Morgan Stanley, Maintained "Tenet Healthcare Corporation" (THC) at Sell with Increased Target from $15 to $16 on, Feb 28th, 2018.

Andrew has made no other calls on THC in the last 4 months.



There are 4 other peers that have a rating on THC. Out of the 4 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Credit Suisse" Initiated at Hold and Held Target at $15 on, Thursday, November 2nd, 2017


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Gary Taylor of "JP Morgan" Downgraded from Hold to Sell on, Thursday, December 14th, 2017
  • Ralph Giacobbe of "Citigroup" Upgraded from Hold to Strong Buy on, Tuesday, December 12th, 2017
  • Brian Tanquilut of "Jefferies" Maintained at Strong Buy with Decreased Target to $20 on, Monday, October 30th, 2017